{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:10:08Z","timestamp":1793232608288,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Behavior change and medication adherence represent potential barriers to optimal prevention of pregnancy complications including preeclampsia. We sought to evaluate baseline sentiments on pregnancy care and medication amenability, and how these measures would be impacted by early predictive testing for preeclampsia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed a digital survey to query participants\u2019 baseline sentiments on pregnancy care, knowledge about pregnancy complications, and views on a hypothetical test to predict preeclampsia. The survey was administered online to pregnant and recently-delivered individuals in the United States. Survey data were analyzed using pooled two-sample proportion z-tests with adjustment for multiple comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>One thousand and twenty-two people completed the survey. 84% reported they were satisfied with their pregnancy care. Self-assessed knowledge about preeclampsia was high, with 75% of respondents reporting they have a \u201cgood understanding\u201d of preeclampsia, but measured knowledge was low, with only 10% able to identify five common signs\/symptoms of preeclampsia. Notably, 40% of participants with prior preeclampsia believed they were at average or below-average risk for recurrence. 91% of participants desired early pregnancy predictive testing for preeclampsia. If found to be at high risk for preeclampsia, 88% reported they would be more motivated to follow their provider\u2019s medication recommendations and 94% reported they would desire home blood pressure monitoring. Increased motivation to follow clinicians\u2019 medication and monitoring recommendations was observed across the full spectrum of medication amenability. Individuals who are more medication-hesitant still reported high rates of motivation to change behavior and adhere to medication recommendations if predictive testing showed a high risk of preeclampsia. Importantly, a high proportion of medication-hesitant individuals reported that if a predictive test demonstrated they were at high risk of preeclampsia, they would feel more motivated to take medications (83.0%) and aspirin (75.9%) if recommended.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While satisfaction with care is high, participants desire more information about their pregnancy health, would value predictive testing for preeclampsia, and report they would act on this information. Improved detection of at-risk individuals through objective testing combined with increased adherence to their recommended care plan may be an important step to remedy the growing gap in prevention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-024-06397-z","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T07:07:17Z","timestamp":1710313637000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of early preeclampsia prediction on medication adherence and behavior change: a survey of pregnant and recently-delivered individuals"],"prefix":"10.1186","volume":"24","author":[{"given":"Alison","family":"Cowan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Haverty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reece","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkady","family":"Khodursky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"key":"6397_CR1","unstructured":"American College of Obstetricians and Gynecologists. Redesigning prenatal care initiative. 2022. https:\/\/www.acog.org\/programs\/redesigning-prenatal-care-initiative. Accessed 21 June 2023."},{"key":"6397_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2023.100941","author":"DP Mallampati","year":"2023","unstructured":"Mallampati DP, Talati AN, Fitzhugh C, Enayet N, Vladutiu CJ, Menard MK. Statewide assessment of telehealth use for obstetrical care during the COVID-19 pandemic. Am J Obstet Gynecol MFM. 2023. https:\/\/doi.org\/10.1016\/j.ajogmf.2023.100941.","journal-title":"Am J Obstet Gynecol MFM"},{"key":"6397_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04249-w","author":"M Rasmussen","year":"2022","unstructured":"Rasmussen M, Reddy M, Nolan R, Camunas-Soler J, Khodursky A, Scheller NM, et al. RNA profiles reveal signatures of future health and disease in pregnancy. Nature. 2022. https:\/\/doi.org\/10.1038\/s41586-021-04249-w.","journal-title":"Nature"},{"key":"6397_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04410-z","author":"MN Moufarrej","year":"2022","unstructured":"Moufarrej MN, Vorperian SK, Wong RJ, Campos AA, Quaintance CC, Sit RV, et al. Early prediction of preeclampsia in pregnancy with cell-free RNA. Nature. 2022. https:\/\/doi.org\/10.1038\/s41586-022-04410-z.","journal-title":"Nature"},{"key":"6397_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.605219.Erratum.In:FrontPediatr.2021Apr,12(9),pp.680201","author":"MN Moufarrej","year":"2020","unstructured":"Moufarrej MN, Wong RJ, Shaw GM, Stevenson DK, Quake SR. Investigating pregnancy and its complications using circulating cell-free RNA in women\u2019s blood during gestation. Front Pediatr. 2020. https:\/\/doi.org\/10.3389\/fped.2020.605219.Erratum.In:FrontPediatr.2021Apr,12(9),pp.680201.","journal-title":"Front Pediatr"},{"key":"6397_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cells11152428","author":"M Ogoyama","year":"2022","unstructured":"Ogoyama M, Takahashi H, Suzuki H, Ohkuchi A, Fujiwara H, Takizawa T. Non-coding RNAs and prediction of preeclampsia in the first trimester of pregnancy. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11152428.","journal-title":"Cells"},{"key":"6397_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1685964","author":"AL Tarca","year":"2021","unstructured":"Tarca AL, Romero R, Erez O, Gudicha DW, Than NG, Benshalom-Tirosh N. Maternal whole blood mRNA signatures identify women at risk of early preeclampsia: a longitudinal study. J Matern Fetal Neonatal Med. 2021. https:\/\/doi.org\/10.1080\/14767058.2019.1685964.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"6397_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2023.04.023","author":"JM Roberts","year":"2023","unstructured":"Roberts JM, King TL, Barton JR, Beck S, Bernstein IM, Buck TE, et al. Care plan for individuals at risk for preeclampsia: shared approach to education, strategies for prevention, surveillance, and follow-up. Am J Obstet Gynecol. 2023. https:\/\/doi.org\/10.1016\/j.ajog.2023.04.023.","journal-title":"Am J Obstet Gynecol"},{"key":"6397_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/796590","author":"D Matsui","year":"2012","unstructured":"Matsui D. Adherence with drug therapy in pregnancy. Obstet Gynecol Int. 2012. https:\/\/doi.org\/10.1155\/2012\/796590.","journal-title":"Obstet Gynecol Int"},{"key":"6397_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034529","author":"S Roldan Munoz","year":"2020","unstructured":"Roldan Munoz S, Lupattelli A, de Vries ST, Mol PGM, Nordeng H. Differences in medication beliefs between pregnant women using medication, or not, for chronic diseases: a cross-sectional, multinational, web-based study. BMJ Open. 2020. https:\/\/doi.org\/10.1136\/bmjopen-2019-034529.","journal-title":"BMJ Open"},{"key":"6397_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2016.08.232","author":"CN Abheiden","year":"2016","unstructured":"Abheiden CN, van Reuler AV, Fuijkschot WW, de Vries JI, Thijs A, de Boer MA. Aspirin adherence during high-risk pregnancies, a questionnaire study. Pregnancy Hypertens. 2016. https:\/\/doi.org\/10.1016\/j.preghy.2016.08.232.","journal-title":"Pregnancy Hypertens"},{"key":"6397_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-022-05218-5","author":"A Davies","year":"2023","unstructured":"Davies A, Mullin S, Chapman S, Barnard K, Bakhbakhi D, Ion R, et al. Interventions to enhance medication adherence in pregnancy- a systematic review. BMC Pregnancy Childbirth. 2023. https:\/\/doi.org\/10.1186\/s12884-022-05218-5.","journal-title":"BMC Pregnancy Childbirth"},{"key":"6397_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2014.07.022","author":"HM Mamudu","year":"2014","unstructured":"Mamudu HM, Paul TK, Veeranki SP, Budoff M. The effects of coronary artery calcium screening on behavioral modification, risk perception, and medication adherence among asymptomatic adults: a systematic review. Atherosclerosis. 2014. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.07.022.","journal-title":"Atherosclerosis"},{"key":"6397_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MCA.0000000000000207","author":"NK Kalia","year":"2015","unstructured":"Kalia NK, Cespedes L, Youssef G, Li D, Budoff MJ. Motivational effects of coronary artery calcium scores on statin adherence and weight loss. Coron Artery Dis. 2015. https:\/\/doi.org\/10.1097\/MCA.0000000000000207.","journal-title":"Coron Artery Dis"},{"key":"6397_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.11.059","author":"RH Orakzai","year":"2008","unstructured":"Orakzai RH, Nasir K, Orakzai SH, Kalia N, Gopal A, Musunuru K, et al. Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors. Am J Cardiol. 2008. https:\/\/doi.org\/10.1016\/j.amjcard.2007.11.059.","journal-title":"Am J Cardiol"},{"key":"6397_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2005.06.018","author":"NK Kalia","year":"2006","unstructured":"Kalia NK, Miller LG, Nasir K, Blumenthal RS, Agrawal N, Budoff MJ. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis. 2006. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2005.06.018.","journal-title":"Atherosclerosis"},{"key":"6397_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.062746","author":"AT Sandhu","year":"2023","unstructured":"Sandhu AT, Rodriguez F, Ngo S, Patel BN, Mastrodicasa D, Eng D. Incidental coronary artery calcium: opportunistic screening of previous nongated chest computed tomography scans to improve statin rates (NOTIFY-1 Project). Circulation. 2023. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062746.","journal-title":"Circulation"},{"issue":"6","key":"6397_CR18","doi-asserted-by":"publisher","first-page":"e2317641","DOI":"10.1001\/jamanetworkopen.2023.17641.PMID:37347486;PMCID:PMC10288331","volume":"6","author":"DA Fink","year":"2023","unstructured":"Fink DA, Kilday D, Cao Z, Larson K, Smith A, Lipkin C, Perigard R, Marshall R, Deirmenjian T, Finke A, Tatum D, Rosenthal N. Trends in maternal mortality and severe maternal morbidity during delivery-related hospitalizations in the United States, 2008 to 2021. JAMA Netw Open. 2023;6(6):e2317641. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.17641.PMID:37347486;PMCID:PMC10288331.","journal-title":"JAMA Netw Open"},{"key":"6397_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-021-04144-2","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Brewer A, Tsigas EZ, Rogers C, Chappell L, Hewison J. Women\u2019s attitudes, beliefs and values about tests, and management for hypertensive disorders of pregnancy. BMC Pregnancy Childbirth. 2021. https:\/\/doi.org\/10.1186\/s12884-021-04144-2.","journal-title":"BMC Pregnancy Childbirth"},{"key":"6397_CR20","doi-asserted-by":"publisher","DOI":"10.3109\/10641955.2010.507851","author":"WB You","year":"2012","unstructured":"You WB, Wolf M, Bailey SC, Pandit AU, Waite KR, Sobel RM, et al. Factors associated with patient understanding of preeclampsia. Hypertens Pregnancy. 2012. https:\/\/doi.org\/10.3109\/10641955.2010.507851.","journal-title":"Hypertens Pregnancy"},{"key":"6397_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/10641955.2017.1397691","author":"J Wilkinson","year":"2018","unstructured":"Wilkinson J, Cole G. Preeclampsia knowledge among women in Utah. Hypertens Pregnancy. 2018. https:\/\/doi.org\/10.1080\/10641955.2017.1397691.","journal-title":"Hypertens Pregnancy"},{"key":"6397_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.14781","author":"KW Davidson","year":"2021","unstructured":"US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force recommendation statement. JAMA. 2021. https:\/\/doi.org\/10.1001\/jama.2021.14781.","journal-title":"JAMA"},{"key":"6397_CR23","doi-asserted-by":"publisher","unstructured":"Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin No 222. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2020. https:\/\/doi.org\/10.1097\/AOG.0000000000003891.","DOI":"10.1097\/AOG.0000000000003891"},{"key":"6397_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012042.pub2","author":"V Zaugg","year":"2018","unstructured":"Zaugg V, Korb-Savoldelli V, Durieux P, Sabatier B. Providing physicians with feedback on medication adherence for people with chronic diseases taking long-term medication. Cochrane Database Syst Rev. 2018. https:\/\/doi.org\/10.1002\/14651858.CD012042.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"6397_CR25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.768986","author":"PM Ho","year":"2009","unstructured":"Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.768986.","journal-title":"Circulation"},{"key":"6397_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.706820","author":"CA Jackevicius","year":"2008","unstructured":"Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.706820.","journal-title":"Circulation"},{"key":"6397_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.14107","author":"R Shanmugalingam","year":"2020","unstructured":"Shanmugalingam R, Wang X, Motum P, Fulcher I, Lee G, Kumar R, et al. Clinical influence of nonadherence with prophylactic aspirin in preventing preeclampsia in high-risk pregnancies: a multicenter, prospective, observational cohort study. Hypertension. 2020. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.14107.","journal-title":"Hypertension"},{"key":"6397_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.08.110","author":"D Wright","year":"2017","unstructured":"Wright D, Poon LC, Rolnik DL, Syngelaki A, Delgado JL, Vojtassakova D, et al. Aspirin for evidence-based preeclampsia prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia. Am J Obstet Gynecol. 2017. https:\/\/doi.org\/10.1016\/j.ajog.2017.08.110.","journal-title":"Am J Obstet Gynecol"},{"key":"6397_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13808","author":"P van Montfort","year":"2020","unstructured":"van Montfort P, Scheepers HCJ, van Dooren IMA, Meertens LJE, Zelis M, Zwaan IM, et al. Low-dose-aspirin usage among women with an increased preeclampsia risk: a prospective cohort study. Acta Obstet Gynecol Scand. 2020. https:\/\/doi.org\/10.1111\/aogs.13808.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"6397_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2019.12.001","author":"E Kalafat","year":"2020","unstructured":"Kalafat E, Benlioglu C, Thilaganathan B, Khalil A. Home blood pressure monitoring in the antenatal and postpartum period: a systematic review meta-analysis. Pregnancy Hypertens. 2020. https:\/\/doi.org\/10.1016\/j.preghy.2019.12.001.","journal-title":"Pregnancy Hypertens"},{"key":"6397_CR31","doi-asserted-by":"publisher","first-page":"961","DOI":"10.15585\/mmwr.mm7235e1","volume":"72","author":"YA Mohamoud","year":"2023","unstructured":"Mohamoud YA, Cassidy E, Fuchs E, Womack L, Romero L, Kipling L, et al. Vital signs: maternity care experiences \u2013 United States, April 2023. MMWR Morb Mortal Wkly Rep. 2023;72:961\u20137. https:\/\/doi.org\/10.15585\/mmwr.mm7235e1.","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-024-06397-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-024-06397-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-024-06397-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T07:07:49Z","timestamp":1710313669000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-024-06397-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6397"],"URL":"https:\/\/doi.org\/10.1186\/s12884-024-06397-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3266061\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-3266061\/v1","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,13]]},"assertion":[{"value":"15 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol was deemed IRB-exempt by Advarra Institutional Review Board, Protocol Pro00065596. The study was deemed exempt under the Department of Health and Human Services Regulations at 45 CFR 46.104(d)(2). All participants also provided informed consent to participate. Consent language can be reviewed in the submitted Appendix, which contains the full questionnaire.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors are employees of Mirvie, Inc., the study's funder.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}